pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-148a |
Genomic Coordinates | chr7: 25949919 - 25949986 |
Description | Homo sapiens miR-148a stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-148a-3p | ||||||||||||||||||||||||
Sequence | 44| UCAGUGCACUACAGAACUUUGU |65 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PTPN4 | ||||||||||||||||||||
Synonyms | MEG, PTPMEG, PTPMEG1 | ||||||||||||||||||||
Description | protein tyrosine phosphatase, non-receptor type 4 | ||||||||||||||||||||
Transcript | NM_002830 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PTPN4 | |||||||||||||||||||||
3'UTR of PTPN4 (miRNA target sites are highlighted) |
>PTPN4|NM_002830|3'UTR 1 GAAAGCAAAAAGATCTGGGATATGTGTTGGAAAACTGCTTTCCCTTATGTTCACTGTGCCATAATGCTGCTCGCAGGAAA 81 TGGCATTTTACAAAAAAAAAATGAAGAACTCAAAAAAACTTTGAAAACTTCAGCACTGTTGCACTTTATGTTTTAAAAAA 161 TGTCACTCTTTCAAAATCTATAACTCATGTATTTGAAGACTGTTTCATGCTTTGCTCCGAACAAATAGTAAATAACTGAG 241 TATGTTCAGGGTAATTTATGAAATTTTGTGGTGGTGCCATGCAATCCCCTTTTGGTAGAATTGCCACAAACAAGGCTCAA 321 AATTCTCATCATCTCTGTTATACACCTGTATCATGAAAGCAAAAAGAAGTAAACATCAGGAGTCAGCTCTGGTCTTTTGC 401 AGTGGTTTGCGTACTTACTATACTGATTACCAGATTTTATTTTTAAAATTTTAGCAATATCGTTCTTAATATTAGCCAAT 481 ACACTGCCTATGGATGCAGCACATTTTTCCCTGCACACCCCCTGTAGAGACCTGCCTGCTGCTCAGAAGAAGAAAGATGG 561 AATTTGCTGTTCCCAGGAAATGCTGCACATTGTCCATTTACCAGCATCTTATAGAAAATATAAATATGAATCTACAAATT 641 CTCTTGGATTTAATAATGTAACTTATATTTATCATAAGGTTGGCTTATTCCAAATCATGTGATTTCACATACTTGATGTA 721 AAGGAATGCATGCATTGTGTCTTAACCCCTTAAGTGCCTTGAGACGTCCTTGTATGTCTAACGAAAAGGCACTCATTTGA 801 CCCCACTAGGAGGTATATATGTATATTGTACATTCGTATATTTTTATGCATTTTGAATAAGTTCACATTTTAAAAAACAG 881 CTATATTGAGTGTTATACAGTCAAAGAAGGGTAAGGAAATTCTGTTTCTTACTCAGTACTCGTGATTTGCTATAAGAAGC 961 AAAGATAATTTGTGTTCTACTGAGTGCACACTGCTGCTATGGAATTGTTCAAAATCTGCACATTCCTTTACTTGAGGGAC 1041 TGAGGGGTTACGGTTTAGCAGCTCAACTTTAAAAGATGCTTTTATGCTTCAAATTTCATATTTATTTCATCCCTAACTTT 1121 AGGAAGACATCTAACATGCAGATTAATGTTAAACATATTGATAATCTAAGCTAAAGTTAGAGCAAATAATTGTGATTTAT 1201 TCATGTCCATAACTAAAATATTATTCTTTAGCACTCATTTCAGTTAATATCAAGCTTTGTTCACACTGATATATTGATTG 1281 GGATTCTTCAAACGAAGAATGAAACATTATTGACTTATTTCTAAGTGTAATAACTCAATAACTAAATTGAGAATTTTCTT 1361 GTTTTTTTGTGTACAATTAAATTATTCCATTTTATATATACTTATTAAGTTATAAGCATGTTAATAAGGAGACTTTTGAC 1441 TGTCCAGCCTAATGGAGGATCTGATTCCCATTAAGGATGTGGGAATTCCCGTATTTTCCTCTTCAGGTTTTTTTGTTTTT 1521 AAGTCTACAGAGAGATAGAACCTTAACATTGCCCAGTTTGATAAAAGTGAAAATTTGCTCACCTATACAAATGTTATTTT 1601 ACACAATTATTTTATGTGGATTGGGGTTTTAAAAGATTCATTTCCTAGCAGTTTCTGAATATTTCTGTAAGATCTTGATA 1681 AAGTTTAGAGTCAAATGGCAGATATTTTGGAAAGCCATTTAGTATGAGGGGAAGAGTACACATTTTAAATCTTTGGTATA 1761 ATCTAAACGATGTCATTTCAGACATTCAAAACTCATAATAATAAATTTCAGGAAATCAAGCTCCTAAACATTAATAGCCA 1841 AGATACCAAATAAATTATCATATTAAAATATTTAAGTTTATTTAAAGAGAGAAGTAAACATAAACTTATGTCAAAGAGAA 1921 ATTCTCTTAATCTATTTCCTGACTTCACAGTCAAAACAGTATAAGATAGTGAAGTAACTTATAATCTTATTTGGTCATTC 2001 TGTTCTATAAACAGACAAATATAATTTAGGCTGCTATATGACATGATAAATTAAAAACTGAGAAAGTAAAATTATGTCGG 2081 GGTCTACACATTAAATGACTGTTTTGGCAGTTTTTCACCTGAATTTAAAAATAAAATTTGTCTGTTCTATCTGTATGGAC 2161 AGAATATGACAACCATAGACCAAAAGATATCATTGTATAGATGTAAAGAGACAAAAGTCATGGTTGGCATGTTCTTTAAT 2241 TTAGGGCCTTGTTTATACTTGTGAGTTTAATAATTTCTTGGCAATGAGCACTGCTGCCTTTTTAAATCATCAATGCCTGT 2321 CTTTAAATGCCAATCATTAGAAGTTTAGAATTACATTTAAATTTCTCATATATGAATTTTTCATCTGGGAACTACCCACT 2401 GTCGTCATTTTTATGTGCAGAAAAGATCCTTTTTGAAAACCATATTTATTGGGATCTTATTTAAATTTAAATTATCCTTT 2481 ACAACTTCTTAAAATGAATATGCTAATAGATAAGACTTTATCCATTACATCTAAGAACTTTTTAACCTGTATATCAATCT 2561 AAATAGGTTTCTAGAAATAATCCTAGCTTTCATACACCATGTAGTTCTAGACTCCGTCCATATCAGTGTAACATTGTGTG 2641 ATAAAATGCCAAATGTCTTGTATCTAAGCTACGCTCCCACTCTTCCAGCCACCCCTACCTCCCACCTTGACACCCTTAAG 2721 AAAGCAATGCTGACTTTTATTCTGACAAGTGGAAATCAATAGTGGTTAATCAAGTGGATTTTGTAAATGCTAAGAAGTGT 2801 TTGTGAAAACCTTCCCTTTCTGAGTTAGGATTGTTTTTTCCTGTTCATTTCAGGTGTTTTATTGAGCATCTGATTTGTGT 2881 CAGCACCATGTAAATATGATGAGGAGTATTTGGAATAGACTTTACATTCACCAGAAAATTGATAGTATTTGTTAAACCAA 2961 TGCATCCATTCAAAATAGAGGCAGAGTAAACAGCCTAAGAAATGATTTCCTTTCTACAGTCTGCTAGGAGAAAGAGGTGA 3041 GAGGGGAGTGGTTGATGATTTTAATCAAGAGTAAAGGGAACATTTATTACATGAAATCTGACTTCAGTTGTGCAAAGGTA 3121 TGTTAAGACATTAAGACAATTGCTGGAAGGTTTCAAATATGTGTACACACACATAGAGCTACTTTTGTGTGTTTATTTAT 3201 ATGTATATTTCACAAAGGCTAATGCCCACAGAGGAAAATGATTATTTTAACTTCTGGGTTATCATCTGCTGGCAGGGTCT 3281 GATCAGGTCTAGAGTATTTAAGGAAAAGTCTCCTGTCTTCTATCTCCACTAGAAGTACTGCAGCTTGAGAGCTGAAAGGA 3361 ACTTGAAAAATGTTATCCAGTCTTCACTTAGCCCATTTTTATCGGCATTAGGAAATAGGGTTCAGCAATGGTTATTGATT 3441 TAGCAGTCTGGTCTTATATGATCTGCTTTCTAATTATCTATCTAGTATTCCTATATTATACTGGAACTTCAATAAATTAT 3521 AACCTATGTGAATATCATAAATTCTTGTGAATTTTTGTCTATTTCCAGTAGAGAAGCATACTCAGCCAATGTTTTCACTT 3601 AATAACTATGACAACCTTAAAGGATGTCACTTAAGTTAGAAAATAAGCAGGCTTAAGAAGTGATTCTAATTAGGACCCCC 3681 ACTCAGTTTGCTAGTCATGCCTGCCTGACAGAACATAAGCTTTTGTAAAGTATTTAGACTGATAACACATGCAGTATGAA 3761 AACATTATAGACTGCAGTTAGAAGACTAATTTTTTAAAAGCACTCAAAACATAGAACTAAGATTTAGAATATATGTCCAT 3841 TTATAATGAAATAATTTGTGTTCATAATGTGAACATGTAAGATAAGTAAATAAAGCATTACTTGTTTTATAATATCAGGA 3921 AGAGAGAAGGAAACATTAGTTTATAACAATGTGCTATTTAATATCTGTATTTTGAACATTTAAAATACTCTGATGGTAAG 4001 GTTGCCAAAGTAATTTTGAATTCATAAAAATTGTTTATACCACAATAATGTGGGATATGTTTACAGGCTCTTTTATTTTG 4081 TGGTAGTTACTTTATAGTTCAGATGAATTTGCATTTCAGTCACTTATAGTAAATAAAGTATATTAAATATTTGTTGGAAT 4161 AAAAATCTCAATGTAATAGGACATAGATAAATTATGCAACAGCCTGCTTTGATGAAAGCTGGTGCATTATGTGAGCTGCC 4241 ACAGTTAATACTTTGTATTAACATTGCTTACTTCCCCCATTTGCTTCACCTATCTGACTACAATTGCTGGAATCATTCTT 4321 TTTGTGGTGCTTCCTCCAAGTGAAATAACTATGTTATTAAAACCTACTGGATTAATTTTATCAAATATCAGACTTACTGA 4401 TCTCTTGGCAGAGATTTATTGGTGTCTCAGTGTGATCACAATACAAGTTGTAGCAACCATTTTATAAAACTCTTAGAGAA 4481 TTATGTAGATAAAATGGAAATTACATAATCCTAAAACATTTTTGAGGGCTAATTGATAATAATTTCAGCAATTTTATTAA 4561 GAACCCAGTAAATTAATCCCTAATTTGTATGTTTTTTGTTCAACTTACCGTGTCTGCAACCATTATATAGACTTCATTGA 4641 TACTCAGCAATTACTACAGTGTGTCTTACAATGTTATAAAAAACAAACAGCAATCTCTGTTTCTGCCAGAAGTTAGATAT 4721 TTTTTTATAGTCCTGATGAATTTGTTGTGAGTAGACACCACATAGTTATTTCTGTTTGCATATAAATTTGCTGCTATTTA 4801 TTTGTATGTTTTTCTACTGTAGTATGCTATTGATTTCTGAAGTTATAATCATAATTTTTATTTTAGTAATCCAAGCTAAA 4881 TGGGCAACCAGAAGTAATATCTGCTAGGGTGCAATCCATCAGCATTGGTTCAGTGCATATACATAAGTAAACCAGTTTAA 4961 AAAAATTTTACTAAGCAAAAGGTAGTAGCAATATTGCTAGTTAAAGATTACCATTTTAGGGGAAAGTTCAAAGGTTTAAC 5041 TTCCTGAAACCTTTTAAACTTTTCAGTGCAAGAATGAAAATGTTTGAAAGCCTTGTTAAGCTCATAAAAGTTTCATTTAA 5121 ACACTGTAGAGTTTCCTACCTTTGTTGTGTAAAGGATATAGAAAATATTTTTCTATGGACAGAAGGTTGAAACTGTTAAC 5201 TTCTTTAATTTCATTGTTTAAAGGAGATAAAATGTTATTTGTGTGTCTTTCATGCTGTAAAGAAAATGAATGTATCTTTC 5281 AAATGTCATTAGAATTATGGCTTGATTCTAAGGATACTCTATTTGTTTTAAAGTCTACACGGGATTGAAAAGAAAGGGAA 5361 GAGTATTACACTTCATTGTACAAAATGTAATTTTAGAAGAAAAACATTTTCATTATAAACAAGAGCAATCATTGAAGCAT 5441 TTTCAGATATAATGTACATTCTTTTTCATTTTGCTTTGCCTCTAGAATAGAAACTTTTCAGAAAATTTGCACATACTGTT 5521 TGTAAGTATAAAATAATTGAATTCTAGACTTTTGGAGTGTGGAAGGGTGTTTGTGTGTGAAGGTAATAAATGTGTTGCTG 5601 CATGTGTTTACCATAGAGAACGTTGCCAGGCTTTGTCAAATGAGGACATTGTTGTGAGGGTGTGACTTTTGTGAAGCCAG 5681 AAAACTGTGCCTAAGATTCATTACAGTGAGTATGTGCAGAGGCCCCTGACCCAGTAAATGCTTTTTGCCTTTTTATTCCC 5761 AATGTCTTGGACAGTTGAGACAACTTGGCCCAACTCTGAATTGTAGCAGTGATGTCTTATATGCTTACGAGTTTATATTA 5841 ATTCAGCTGAACAAGAACTACATCTTAAACCACCTTTGTAGGTATGATTAATACGTGCAACAGCTGCTTTAAAAGGTGGT 5921 ATTTATTATTCATCACTCATGAAACTTGACTCAGTGAGGACTTCATTATTTTTATTTCTCTTTCCACGTCTCCAACTTTT 6001 TAAAAATCACTAATTTAACTCTTTGTTAAGTACTCAAGTACAAAGTGATCTCTTCTTTCATGAACTTTGCTATAACTGTT 6081 GAAAGGATTGGTGTCAGGCTCTCTCAACCCTGGGAGTTTCCAAAATTTAGCAAATATTACTTGTGATAAGCTTAAATGCC 6161 ACATCGCTAAGTACAATTATTACCAGGAATCCGTCAAGGGGGAGATAGCCCCGCTCACACCCTTAGACCCAAACAGGTGC 6241 TGGTTCATGCTTTCTCCACAAATTGGCAGTTGGGTACTTCCCCACTGTCATCACAGTTGAGCTCATTTTAACATATATTC 6321 AAAGAAGCTTTTTAGTTTCTACTCCTGAATTGTAGTGTTCAAGTTATTTGCCTTCCTGGGTAAGAAAATTTTAACCCAAG 6401 TCTGGGATTCTCTGGCACCTGTCTTTTCCCATCTTTTAATGAGTTGGCAAGATTAGGTCAAATTTCAATGCTAAATTTGA 6481 TTTTTTGAATTTTAAATAGTTGCACTTTATTTCATGCTGACCACCAACTTAATTTATACATTTTAAAATAAAATTATCCT 6561 AGAAGTGTTGTAAACGTGGGAAAATTTTAATTAGTGTTGGAGGTCATTAGATTGGACCCAGGTTTAAATATAATGATCTC 6641 TTCACAGCTTATTTGATGTTTAAGAGCAACTTGTGTGATCTTAGCTTTGCAGGTTTTCTGTAATTTATGTAGCACAATAA 6721 AGGATAACCAGTTGACTGTGTTACTGGACTCTGAGTTCTCACAGCTAGTTTCATCTAAGCTTGGTTTATTATCATTTCTG 6801 CTTTGGATTTTTTTGTGCATCACATGAATACTTAGAAATCCATTTGTTTTCAGTGTAGTACCTAGGGTGAAGTAGATGCT 6881 GCACAAGTAAGTTTAAGGGAATAAAAGTCCCGACACTTTATATACATGTTGAGGGGCACGATTTAAGAGACTGAAACAGT 6961 TTACATTAAACTGTTTTTATTTTCTGCCAGTAGACTCTATCTGCTTAAAAAAATAAAAATTGTTCAACCCAGTGTTCTCC 7041 AGCATCAGGACATTACAGTTGTAATCTATGTTGTAATCTTTTCAAATAAGAAAAGCTACTCCTTATTCTCTACAGTGTAG 7121 GCTTAATTTTAGAACCGATAATTTACTATATCTGCATTATTGATATTTTTAAGTAGTAGTTTTAAAAATAATTATTTCTA 7201 TGTGGAGGGTGTTTTAATTTGGGATTTTTTTTTTCTTGTAACAGGTGCTATTTGTAAATATGAAGGGGAAAAGTCACTTA 7281 GTTAAAAGTCTAGCTTATGTCATAATTAAGATACAATTATTCATTTCATGTTTGATTCTATTAAACTAGTGGCAAAACAG 7361 AATTGGTCCCTTAGTTTTTTAGATTACCTTTCCCCCTATATCACAAAAATATCTCTTTCCATATGATCTCATAATTGAGG 7441 CAAAGAAGCTAAGGGTTTATTTAAAATGTGTATAAGCTTGAATTTGGTCAACACTGCATAATTTGAAATCACTCTGCATT 7521 TGTCACTGCAGCTTACTGTATGCTTGAAAGGCCTTGTGTGTTTGTCTTAATTTTAGTGAAAAAATTAGAATTTCTGCCAT 7601 TCATGTACAAAAAAATTACAACTACAGCAAACAAGATAAAAATGCTGGTTTGCATTAATACTGTTTTAGTCTTAAGAGCA 7681 ATTTATATTATGTGAAATGCTGTTACACATATTTTGTTGGCCATATTTCATTTTGAGAAACAGTTGTTCAGGTACAAACA 7761 TGACAAACAACTCTAGCTATGACTCTTAATGTTCAATTGCAAAATAAAGATGTGCTTTAGTAATCTAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
205 hsa-miR-148a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT000020 | DNMT1 | DNA methyltransferase 1 | 7 | 7 | ||||||||
MIRT000297 | HLA-G | major histocompatibility complex, class I, G | 2 | 1 | ||||||||
MIRT000298 | TGIF2 | TGFB induced factor homeobox 2 | 3 | 2 | ||||||||
MIRT000955 | DNMT3B | DNA methyltransferase 3 beta | 5 | 2 | ||||||||
MIRT003998 | NR1I2 | nuclear receptor subfamily 1 group I member 2 | 7 | 2 | ||||||||
MIRT004504 | RPS6KA5 | ribosomal protein S6 kinase A5 | 4 | 1 | ||||||||
MIRT005898 | CCKBR | cholecystokinin B receptor | 4 | 3 | ||||||||
MIRT006859 | IRS1 | insulin receptor substrate 1 | 2 | 1 | ||||||||
MIRT006946 | ACVR1 | activin A receptor type 1 | 2 | 2 | ||||||||
MIRT006975 | BCL2 | BCL2, apoptosis regulator | 1 | 1 | ||||||||
MIRT007017 | TMED7 | transmembrane p24 trafficking protein 7 | 1 | 1 | ||||||||
MIRT025970 | GPATCH8 | G-patch domain containing 8 | 1 | 1 | ||||||||
MIRT025971 | TMEM14A | transmembrane protein 14A | 1 | 1 | ||||||||
MIRT025972 | ANP32A | acidic nuclear phosphoprotein 32 family member A | 1 | 1 | ||||||||
MIRT025973 | RAB1B | RAB1B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT025974 | HSP90B1 | heat shock protein 90 beta family member 1 | 1 | 1 | ||||||||
MIRT025975 | POFUT1 | protein O-fucosyltransferase 1 | 1 | 1 | ||||||||
MIRT025976 | CYCS | cytochrome c, somatic | 1 | 1 | ||||||||
MIRT025977 | ADARB1 | adenosine deaminase, RNA specific B1 | 1 | 1 | ||||||||
MIRT025978 | CBX3 | chromobox 3 | 1 | 1 | ||||||||
MIRT025979 | UQCRQ | ubiquinol-cytochrome c reductase complex III subunit VII | 1 | 1 | ||||||||
MIRT025980 | SPRY2 | sprouty RTK signaling antagonist 2 | 1 | 1 | ||||||||
MIRT025981 | PAN3 | PAN3 poly(A) specific ribonuclease subunit | 1 | 1 | ||||||||
MIRT025982 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 1 | 1 | ||||||||
MIRT025983 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT025984 | PTPN4 | protein tyrosine phosphatase, non-receptor type 4 | 1 | 1 | ||||||||
MIRT025985 | ZNF92 | zinc finger protein 92 | 1 | 1 | ||||||||
MIRT025986 | RAB10 | RAB10, member RAS oncogene family | 1 | 1 | ||||||||
MIRT025987 | PAPD4 | poly(A) RNA polymerase D4, non-canonical | 2 | 3 | ||||||||
MIRT025988 | HCCS | holocytochrome c synthase | 1 | 1 | ||||||||
MIRT025989 | WAPAL | WAPL cohesin release factor | 1 | 1 | ||||||||
MIRT025990 | MPP5 | membrane palmitoylated protein 5 | 1 | 1 | ||||||||
MIRT025991 | ZNF490 | zinc finger protein 490 | 1 | 1 | ||||||||
MIRT025992 | RAB12 | RAB12, member RAS oncogene family | 2 | 3 | ||||||||
MIRT025993 | GNB5 | G protein subunit beta 5 | 1 | 1 | ||||||||
MIRT025994 | SNAPIN | SNAP associated protein | 2 | 3 | ||||||||
MIRT025995 | PSMD9 | proteasome 26S subunit, non-ATPase 9 | 1 | 1 | ||||||||
MIRT025996 | TRIM59 | tripartite motif containing 59 | 1 | 1 | ||||||||
MIRT025997 | DYNLL2 | dynein light chain LC8-type 2 | 1 | 1 | ||||||||
MIRT025998 | SECISBP2L | SECIS binding protein 2 like | 2 | 6 | ||||||||
MIRT025999 | LYSMD1 | LysM domain containing 1 | 1 | 1 | ||||||||
MIRT026000 | PBXIP1 | PBX homeobox interacting protein 1 | 2 | 2 | ||||||||
MIRT026001 | MTMR9 | myotubularin related protein 9 | 1 | 1 | ||||||||
MIRT026002 | DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 | 1 | 1 | ||||||||
MIRT026003 | DSTYK | dual serine/threonine and tyrosine protein kinase | 1 | 1 | ||||||||
MIRT026004 | LBR | lamin B receptor | 1 | 1 | ||||||||
MIRT026005 | KIAA1549 | KIAA1549 | 1 | 1 | ||||||||
MIRT026006 | DYRK1A | dual specificity tyrosine phosphorylation regulated kinase 1A | 1 | 1 | ||||||||
MIRT026007 | CDK19 | cyclin dependent kinase 19 | 2 | 3 | ||||||||
MIRT026008 | RAB34 | RAB34, member RAS oncogene family | 2 | 3 | ||||||||
MIRT026009 | ARRDC3 | arrestin domain containing 3 | 1 | 1 | ||||||||
MIRT026010 | PRNP | prion protein | 2 | 1 | ||||||||
MIRT026011 | HOXC8 | homeobox C8 | 4 | 1 | ||||||||
MIRT026012 | TMEM9B | TMEM9 domain family member B | 1 | 1 | ||||||||
MIRT026013 | RASSF8 | Ras association domain family member 8 | 1 | 1 | ||||||||
MIRT026014 | BTBD3 | BTB domain containing 3 | 2 | 12 | ||||||||
MIRT026015 | TNRC6A | trinucleotide repeat containing 6A | 2 | 3 | ||||||||
MIRT026016 | SESTD1 | SEC14 and spectrin domain containing 1 | 1 | 1 | ||||||||
MIRT026017 | CDC25B | cell division cycle 25B | 3 | 1 | ||||||||
MIRT048023 | MRPL45 | mitochondrial ribosomal protein L45 | 1 | 1 | ||||||||
MIRT048024 | DENR | density regulated re-initiation and release factor | 1 | 1 | ||||||||
MIRT048025 | APPBP2 | amyloid beta precursor protein binding protein 2 | 1 | 1 | ||||||||
MIRT048026 | SLC2A3 | solute carrier family 2 member 3 | 1 | 1 | ||||||||
MIRT048027 | PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 1 | 1 | ||||||||
MIRT048028 | VPS41 | VPS41, HOPS complex subunit | 1 | 1 | ||||||||
MIRT048029 | MSL3 | MSL complex subunit 3 | 1 | 1 | ||||||||
MIRT048030 | AMELX | amelogenin, X-linked | 1 | 1 | ||||||||
MIRT048031 | OR2C3 | olfactory receptor family 2 subfamily C member 3 | 1 | 1 | ||||||||
MIRT048032 | SLC25A3 | solute carrier family 25 member 3 | 1 | 1 | ||||||||
MIRT048033 | APC | APC, WNT signaling pathway regulator | 1 | 1 | ||||||||
MIRT048034 | GOLIM4 | golgi integral membrane protein 4 | 1 | 1 | ||||||||
MIRT048035 | MYCBP2 | MYC binding protein 2, E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT048036 | RPS17 | ribosomal protein S17 | 1 | 1 | ||||||||
MIRT048037 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 1 | 1 | ||||||||
MIRT048038 | WDTC1 | WD and tetratricopeptide repeats 1 | 1 | 1 | ||||||||
MIRT048039 | HMGB1 | high mobility group box 1 | 1 | 1 | ||||||||
MIRT048040 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 4 | 2 | ||||||||
MIRT048041 | USP38 | ubiquitin specific peptidase 38 | 1 | 1 | ||||||||
MIRT048042 | NONO | non-POU domain containing octamer binding | 1 | 1 | ||||||||
MIRT048043 | CCNI | cyclin I | 1 | 1 | ||||||||
MIRT048044 | AURKB | aurora kinase B | 1 | 1 | ||||||||
MIRT052917 | MMP7 | matrix metallopeptidase 7 | 4 | 1 | ||||||||
MIRT053185 | WNT10B | Wnt family member 10B | 4 | 1 | ||||||||
MIRT053199 | MYC | MYC proto-oncogene, bHLH transcription factor | 2 | 1 | ||||||||
MIRT053475 | CDKN1B | cyclin dependent kinase inhibitor 1B | 4 | 5 | ||||||||
MIRT053477 | SERPINE1 | serpin family E member 1 | 3 | 1 | ||||||||
MIRT053478 | ITGB8 | integrin subunit beta 8 | 5 | 3 | ||||||||
MIRT053479 | VAV2 | vav guanine nucleotide exchange factor 2 | 3 | 1 | ||||||||
MIRT053480 | ITGA5 | integrin subunit alpha 5 | 3 | 1 | ||||||||
MIRT053483 | ROCK1 | Rho associated coiled-coil containing protein kinase 1 | 6 | 3 | ||||||||
MIRT053518 | RUNX3 | runt related transcription factor 3 | 2 | 1 | ||||||||
MIRT053560 | SMAD2 | SMAD family member 2 | 3 | 1 | ||||||||
MIRT054115 | UNKL | unkempt family like zinc finger | 1 | 1 | ||||||||
MIRT054388 | MET | MET proto-oncogene, receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT057492 | CEP55 | centrosomal protein 55 | 2 | 4 | ||||||||
MIRT062708 | MLEC | malectin | 2 | 4 | ||||||||
MIRT084562 | BCL2L11 | BCL2 like 11 | 2 | 1 | ||||||||
MIRT105304 | VPS37A | VPS37A, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT130076 | TXNIP | thioredoxin interacting protein | 4 | 4 | ||||||||
MIRT138426 | KIF2C | kinesin family member 2C | 2 | 2 | ||||||||
MIRT152411 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT155749 | SIK1 | salt inducible kinase 1 | 2 | 6 | ||||||||
MIRT210293 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT218522 | HLA-A | major histocompatibility complex, class I, A | 2 | 2 | ||||||||
MIRT222270 | CCT6A | chaperonin containing TCP1 subunit 6A | 2 | 2 | ||||||||
MIRT270936 | GPRC5A | G protein-coupled receptor class C group 5 member A | 2 | 2 | ||||||||
MIRT280554 | GLRX5 | glutaredoxin 5 | 2 | 2 | ||||||||
MIRT281136 | PDIA3 | protein disulfide isomerase family A member 3 | 3 | 1 | ||||||||
MIRT296526 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT301572 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT347400 | CEBPG | CCAAT/enhancer binding protein gamma | 2 | 2 | ||||||||
MIRT382244 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT399584 | RBM38 | RNA binding motif protein 38 | 2 | 2 | ||||||||
MIRT437409 | MAFB | MAF bZIP transcription factor B | 1 | 1 | ||||||||
MIRT438088 | ERRFI1 | ERBB receptor feedback inhibitor 1 | 2 | 1 | ||||||||
MIRT438751 | S1PR1 | sphingosine-1-phosphate receptor 1 | 3 | 3 | ||||||||
MIRT438752 | USP4 | ubiquitin specific peptidase 4 | 3 | 1 | ||||||||
MIRT453164 | CNOT4 | CCR4-NOT transcription complex subunit 4 | 2 | 6 | ||||||||
MIRT456196 | ZDHHC6 | zinc finger DHHC-type containing 6 | 2 | 2 | ||||||||
MIRT458103 | TTLL1 | tubulin tyrosine ligase like 1 | 2 | 2 | ||||||||
MIRT459958 | POC1A | POC1 centriolar protein A | 2 | 2 | ||||||||
MIRT461329 | MRPS27 | mitochondrial ribosomal protein S27 | 2 | 2 | ||||||||
MIRT462848 | B4GALT7 | beta-1,4-galactosyltransferase 7 | 2 | 2 | ||||||||
MIRT463247 | ZIC5 | Zic family member 5 | 2 | 2 | ||||||||
MIRT464041 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT466869 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT467697 | SLC38A2 | solute carrier family 38 member 2 | 2 | 4 | ||||||||
MIRT468920 | RPS6KA4 | ribosomal protein S6 kinase A4 | 2 | 2 | ||||||||
MIRT469506 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT469815 | RAB14 | RAB14, member RAS oncogene family | 2 | 2 | ||||||||
MIRT470329 | PPP6R1 | protein phosphatase 6 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT473770 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 5 | 3 | ||||||||
MIRT477363 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT478215 | DDX6 | DEAD-box helicase 6 | 2 | 2 | ||||||||
MIRT479812 | CCNA2 | cyclin A2 | 2 | 6 | ||||||||
MIRT484939 | ZFYVE26 | zinc finger FYVE-type containing 26 | 2 | 4 | ||||||||
MIRT485432 | KLF6 | Kruppel like factor 6 | 9 | 3 | ||||||||
MIRT485645 | DICER1 | dicer 1, ribonuclease III | 2 | 4 | ||||||||
MIRT487938 | HLA-C | major histocompatibility complex, class I, C | 3 | 2 | ||||||||
MIRT488937 | ETV7 | ETS variant 7 | 2 | 2 | ||||||||
MIRT492821 | PATL1 | PAT1 homolog 1, processing body mRNA decay factor | 2 | 2 | ||||||||
MIRT496749 | PDIK1L | PDLIM1 interacting kinase 1 like | 2 | 2 | ||||||||
MIRT497883 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT500918 | STARD13 | StAR related lipid transfer domain containing 13 | 2 | 4 | ||||||||
MIRT503176 | AGO2 | argonaute 2, RISC catalytic component | 2 | 4 | ||||||||
MIRT505102 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 2 | 2 | ||||||||
MIRT505256 | UBE2D3 | ubiquitin conjugating enzyme E2 D3 | 2 | 2 | ||||||||
MIRT511220 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 4 | ||||||||
MIRT513209 | RFT1 | RFT1 homolog | 2 | 2 | ||||||||
MIRT513617 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT522804 | KPNA4 | karyopherin subunit alpha 4 | 2 | 4 | ||||||||
MIRT525443 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT530302 | AKAP17A | A-kinase anchoring protein 17A | 2 | 2 | ||||||||
MIRT531689 | MYO3A | myosin IIIA | 2 | 2 | ||||||||
MIRT537300 | FZD5 | frizzled class receptor 5 | 2 | 2 | ||||||||
MIRT541199 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 2 | ||||||||
MIRT544732 | NDRG1 | N-myc downstream regulated 1 | 2 | 2 | ||||||||
MIRT549174 | BMP3 | bone morphogenetic protein 3 | 2 | 2 | ||||||||
MIRT549231 | BAZ2B | bromodomain adjacent to zinc finger domain 2B | 2 | 2 | ||||||||
MIRT551864 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT559687 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT561658 | RNF219 | ring finger protein 219 | 2 | 2 | ||||||||
MIRT561856 | NPTX1 | neuronal pentraxin 1 | 2 | 2 | ||||||||
MIRT565733 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT566568 | OTUD4 | OTU deubiquitinase 4 | 2 | 2 | ||||||||
MIRT567186 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT567834 | DCUN1D3 | defective in cullin neddylation 1 domain containing 3 | 2 | 2 | ||||||||
MIRT574794 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT576772 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT610545 | WNT2B | Wnt family member 2B | 2 | 4 | ||||||||
MIRT613042 | FOXP1 | forkhead box P1 | 2 | 2 | ||||||||
MIRT615073 | COLEC12 | collectin subfamily member 12 | 2 | 2 | ||||||||
MIRT617481 | AP5B1 | adaptor related protein complex 5 beta 1 subunit | 2 | 2 | ||||||||
MIRT622753 | PHACTR2 | phosphatase and actin regulator 2 | 2 | 2 | ||||||||
MIRT625516 | PPAPDC1A | phospholipid phosphatase 4 | 2 | 2 | ||||||||
MIRT628641 | ABLIM1 | actin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT630234 | SORD | sorbitol dehydrogenase | 2 | 2 | ||||||||
MIRT635946 | PLA2G12A | phospholipase A2 group XIIA | 2 | 2 | ||||||||
MIRT646776 | IL23R | interleukin 23 receptor | 2 | 2 | ||||||||
MIRT648163 | CHRFAM7A | CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion | 2 | 2 | ||||||||
MIRT653244 | SOS2 | SOS Ras/Rho guanine nucleotide exchange factor 2 | 5 | 2 | ||||||||
MIRT661182 | S1PR2 | sphingosine-1-phosphate receptor 2 | 2 | 2 | ||||||||
MIRT693234 | KIAA0907 | KIAA0907 | 2 | 4 | ||||||||
MIRT693776 | VGLL2 | vestigial like family member 2 | 2 | 2 | ||||||||
MIRT702589 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 2 | ||||||||
MIRT715175 | DTX4 | deltex E3 ubiquitin ligase 4 | 2 | 2 | ||||||||
MIRT722871 | FAM212B | family with sequence similarity 212 member B | 2 | 2 | ||||||||
MIRT723139 | YPEL1 | yippee like 1 | 2 | 2 | ||||||||
MIRT723186 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT732353 | WNT1 | Wnt family member 1 | 3 | 1 | ||||||||
MIRT732362 | STAT3 | signal transducer and activator of transcription 3 | 3 | 1 | ||||||||
MIRT734547 | HNRNPK | heterogeneous nuclear ribonucleoprotein K | 2 | 0 | ||||||||
MIRT734935 | CXCR4 | C-X-C motif chemokine receptor 4 | 1 | 0 | ||||||||
MIRT736034 | ITGA9 | integrin subunit alpha 9 | 3 | 0 | ||||||||
MIRT736105 | PTEN | phosphatase and tensin homolog | 5 | 1 | ||||||||
MIRT736114 | IL15 | interleukin 15 | 2 | 0 | ||||||||
MIRT736501 | AKT1 | AKT serine/threonine kinase 1 | 1 | 0 | ||||||||
MIRT737228 | PCGEM1 | PCGEM1, prostate-specific transcript (non-protein coding) | 2 | 0 | ||||||||
MIRT737363 | UBAP2 | ubiquitin associated protein 2 | 3 | 0 | ||||||||
MIRT737364 | FOXK2 | forkhead box K2 | 3 | 0 | ||||||||
MIRT755397 | WNT10A | Wnt family member 10A | 2 | 1 | ||||||||
MIRT755440 | LDLR | low density lipoprotein receptor | 1 | 1 | ||||||||
MIRT756258 | CDK5R1 | cyclin dependent kinase 5 regulatory subunit 1 | 3 | 1 | ||||||||
MIRT756289 | SLC7A11 | solute carrier family 7 member 11 | 2 | 1 | ||||||||
MIRT756402 | CNTN4 | contactin 4 | 2 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|